Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Advancements in paediatric Acute lymphoblastic leukemia management

Dr Ruchi Aujla - Balco Medical Center, Raipur, India
Advancements in paediatric Acute lymphoblastic leukemia management ( Dr Ruchi Aujla - Balco Medical Center, Raipur, India )
9 Oct 2024

Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies

Prof Philippe Moreau - University Hospital of Nantes, Nantes, France
Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies ( Prof Philippe Moreau - University Hospital of Nantes, Nantes, France )
30 Sep 2024

Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC

Dr Marina Garassino - University of Chicago, Chicago, USA
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC ( Dr Marina Garassino - University of Chicago, Chicago, USA )
26 Sep 2024

Choosing 1st line TKI Wisely in patients with CML

Dr Prashant Mehta - Amrita Hospirtal, Karala, India
Choosing 1st line TKI Wisely in patients with CML ( Dr Prashant Mehta - Amrita Hospirtal, Karala, India )
26 Sep 2024

Choosing Wisely in endometrial & cervix cancers: Medical therapy

Dr Jaya Ghosh - Tata Memorial Hospital, Mumbai, India
Choosing Wisely in endometrial & cervix cancers: Medical therapy ( Dr Jaya Ghosh - Tata Memorial Hospital, Mumbai, India )
22 Sep 2024

Neoadjuvant ipilimumab added to nivolumab improves outcomes in resectable advanced melanoma

Dr Minke W. Lucas - The Netherlands Cancer Institute, Amsterdam, Netherlands
Neoadjuvant ipilimumab added to nivolumab improves outcomes in resectable advanced melanoma ( Dr Minke W. Lucas - The Netherlands Cancer Institute, Amsterdam, Netherlands )
19 Sep 2024

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer

Prof Karim Fizazi, Dr Anders Bjartell, Dr Niven Mehra and Prof Eleni Efstathiou
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer ( Prof Karim Fizazi, Dr Anders Bjartell, Dr Niven Mehra and Prof Eleni Efstathiou )
19 Sep 2024

No benefit for adjuvant durvalumab in completely resected NSCLC

Prof Glenwood Goss - University of Ottawa, Ottawa, Canada
No benefit for adjuvant durvalumab in completely resected NSCLC ( Prof Glenwood Goss - University of Ottawa, Ottawa, Canada )
17 Sep 2024

ESMO 2024: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2024: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
16 Sep 2024

Watchful waiting vs intravesical BCG in high grade pT1 bladder cancer

Dr Hiroshi Kitamura - University of Toyama, Toyama, Japan
Watchful waiting vs intravesical BCG in high grade pT1 bladder cancer ( Dr Hiroshi Kitamura - University of Toyama, Toyama, Japan )
16 Sep 2024

Durvalumab and oleclumab boost for SBRT plus chemo in ER+/HER2- breast cancer

Dr Alex De Caluwe - Institut Jules Bordet, Brussels, Belgium
Durvalumab and oleclumab boost for SBRT plus chemo in ER+/HER2- breast cancer ( Dr Alex De Caluwe - Institut Jules Bordet, Brussels, Belgium )
16 Sep 2024

Faecal microbiota transplantation increases activity of immunotherapy in mRCC

Dr Chiara Ciccarese - Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Faecal microbiota transplantation increases activity of immunotherapy in mRCC ( Dr Chiara Ciccarese - Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy )
16 Sep 2024